These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 29995359

  • 1. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
    Emsley R, Ahokas A, Suarez A, Marinescu D, Dóci I, Lehtmets A, Milanova V, Lee MS, Didi R, Araszkiewicz A, Sulaiman AH, Blanchot FP, Crutel VS, Antoine C, Penelaud PF.
    J Clin Psychiatry; 2018 Jul 03; 79(4):. PubMed ID: 29995359
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 03; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 3. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May 03; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 4. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
    Daléry J, Dagens-Lafant V, De Bodinat C.
    Encephale; 1997 May 03; 23(1):56-64. PubMed ID: 9172969
    [Abstract] [Full Text] [Related]

  • 5. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 May 03; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 6. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
    Findling RL, Robb A, Bose A.
    J Child Adolesc Psychopharmacol; 2013 Sep 03; 23(7):468-80. PubMed ID: 24041408
    [Abstract] [Full Text] [Related]

  • 7. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U, Wade A, Andersen HF.
    Int Clin Psychopharmacol; 2004 May 03; 19(3):149-55. PubMed ID: 15107657
    [Abstract] [Full Text] [Related]

  • 8. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
    Jeon HJ, Woo JM, Lee SH, Kim EJ, Chung S, Ha JH, Fava M, Mischoulon D, Kim JH, Heo JY, Yu BH.
    J Clin Psychopharmacol; 2014 Apr 03; 34(2):218-25. PubMed ID: 24525660
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L, Septien L, Azoulay P.
    CNS Drugs; 2002 Apr 03; 16(1):65-75. PubMed ID: 11772119
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G, Beeské S, Stahl SM.
    J Clin Psychiatry; 2012 Nov 03; 73(11):1403-11. PubMed ID: 23146246
    [Abstract] [Full Text] [Related]

  • 16. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul 03; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
    Trivedi MH, Cutler AJ, Richards C, Lasser R, Geibel BB, Gao J, Sambunaris A, Patkar AA.
    J Clin Psychiatry; 2013 Aug 03; 74(8):802-9. PubMed ID: 24021497
    [Abstract] [Full Text] [Related]

  • 18. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES, Howard C, Khan DA, Carmody TJ.
    Psychosomatics; 2012 Aug 03; 53(1):75-80. PubMed ID: 22221724
    [Abstract] [Full Text] [Related]

  • 19. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
    Rosenberg C, Lauritzen L, Brix J, Jørgensen JB, Kofod P, Bayer LB.
    Psychopharmacol Bull; 2007 Aug 03; 40(1):63-73. PubMed ID: 17285097
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram versus placebo in the treatment of dysthymic disorder.
    Hellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D.
    Int Clin Psychopharmacol; 2010 May 03; 25(3):143-8. PubMed ID: 21811192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.